Macúchová E, Slamberová R
Cesk Fysiol. 2016 Oct;65(1):32-37.
Women, who abuse drugs during pregnancy, expose not just themselves but also their developing fetus to impairing effects, which can have potentially harmful and even long-term effects on the exposed children. For some years, methamphetamine (MA) has dominated the illicit drug market in the Czech Republic and Slovakia; additionally this drug is on the rise worldwide. It is one of the most accessible drugs, and in many cases the first choice drug for many drug-addicted pregnant women; in part due to its anorectic and stimulant effects. These women are rarely aware of the consequences of their behavior and their pregnancy is hardly ever a good enough reason for giving up drug use. These findings are supported by many experimental studies that show the damaging effects of maternal MA exposure on their offspring. There is growing evidence that exposure to MA in utero not only causes birth defects and delays in infant development, but also impairs the brain reward neural pathways of a developing offspring in such a way, that it could increase the predisposition for drug addiction later in life. Previously published animal studies have shown that offspring of mothers exposed to MA during pregnancy are more sensitive to MA when they encounter this drug later in adulthood. With respect to increased sensitivity, the term of sensitization has been introduced. It is defined as augmented psychomotor activity, which can be observed after drug re-administration following discontinuation of repeated drug exposure, and has been demonstrated to develop not only after repeated drug administration in adulthood, but also after chronic prenatal exposure. Results from our studies have shown that prenatal MA exposure can influence the sensitivity to the effects of some drugs, given as a challenge, in adulthood, specifically to those with a similar action mechanism. Our findings indicate that cross-sensitization between prenatal MA exposure and adult drug treatment cannot be simply termed as a general drug addiction, since it seems that the mechanism by which a drug impairs specific neurotransmitter systems plays an important role. The study findings show that although the offspring of MA-addicted mothers have altered sensitivity to certain drugs in adulthood, they do not display increased active drug-seeking behavior. Therefore, if we extrapolate the results to humans, it appears that there is a relatively little risk that a person, whose mother abused MA during pregnancy, will actively seek out drugs.
孕期滥用药物的女性不仅会让自己,还会让腹中发育的胎儿受到损害,这可能会对受影响的儿童产生潜在的有害甚至长期影响。多年来,甲基苯丙胺(MA)在捷克共和国和斯洛伐克的非法毒品市场中占据主导地位;此外,这种毒品在全球范围内呈上升趋势。它是最容易获得的毒品之一,在许多情况下是许多吸毒孕妇的首选毒品;部分原因是其具有抑制食欲和刺激作用。这些女性很少意识到自己行为的后果,怀孕也几乎从来都不是她们戒毒的充分理由。许多实验研究支持了这些发现,这些研究表明母体接触甲基苯丙胺会对其后代产生有害影响。越来越多的证据表明,子宫内接触甲基苯丙胺不仅会导致出生缺陷和婴儿发育迟缓,还会损害发育中后代的大脑奖赏神经通路,从而增加其日后成瘾的易感性。此前发表的动物研究表明,孕期接触甲基苯丙胺的母亲的后代在成年后再次接触这种毒品时,对其更为敏感。关于敏感性增加,引入了致敏这个术语。它被定义为增强的精神运动活动,在反复接触毒品后停药再给药时可以观察到,并且已被证明不仅在成年后反复给药后会出现,在慢性产前接触后也会出现。我们的研究结果表明,产前接触甲基苯丙胺会影响成年后对某些作为挑战给予的药物的敏感性,特别是对那些作用机制相似的药物。我们的研究结果表明,产前接触甲基苯丙胺与成年药物治疗之间的交叉致敏不能简单地称为一般的药物成瘾,因为似乎药物损害特定神经递质系统的机制起着重要作用。研究结果表明,虽然成瘾母亲的后代在成年后对某些药物的敏感性发生了改变,但他们并没有表现出增加的主动觅药行为。因此,如果我们将结果外推到人类,似乎母亲在孕期滥用甲基苯丙胺的人主动寻求毒品的风险相对较小。